Hanmi established license contract of diabetes treatments with Sanofi for EUR 400 million
Hanmi Pharm announced on the 5th that Sanofi established a license contract for the Quantum Project, a portfolio of long-acting diabetes new drugs, which has been developed by Hanmi Pharm.
Under the term of the agreement, Hanmi Pharm will receive an upfront payment of EUR 400 million and phased ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
